Heart Valve Repair

News | Heart Valve Repair | November 23, 2015
November 23, 2015 — NaviGate Cardiac Structures Inc. (NCSI) announced that a first-in-human implant of its...
Neovasc, Tiara, transcatheter mitral valve, TMVR

The Neovasc Tiara transcatheter mitral valve is currently being tested in U.S. and international clinical trials. 

Feature | Heart Valve Repair | November 12, 2015 | Dave Fornell
The advent of transcatheter valve repair and replacement technologies is one of those rare instances where there is a...
SALUS trial, Direct Flow Medical TAVR device, Medtronic CoreValve, PinnacleHealth CardioVascular Institute

Image courtesy of Direct Flow Medical

News | Heart Valve Repair | November 10, 2015
November 10, 2015 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a randomized...
Blog | Cath Lab | November 05, 2015
For the past few years, the focus of the annual Transcatheter Cardiovascular Therapeutics (TCT) meetings has been on...
Videos | TCT | November 05, 2015
Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015...
aortic valve replacment, AVR, severe aortic stenosis, CURRENT AS registry, TCT 2015
News | Heart Valve Repair | October 27, 2015
October 27, 2015 — A large observational registry found that initial...
Medtronic CoreValve, real-world clinical outcomes, STS/ACC TVT Registry, TCT 2015

Image courtesy of Medtronic

News | Heart Valve Repair | October 22, 2015
October 22, 2015 — Medtronic plc released the first...
Direct Flow Medical TAVR System, DISCOVER post-market study, real-world results, TCT 2015

Image courtesy of Direct Flow Medical Inc.

News | Heart Valve Repair | October 22, 2015
October 22, 2015 — Direct Flow Medical Inc. announced one-year outcomes from the DISCOVER post-market study that...
BRAVO 3 trial results, bivalirudin, heparin, anticoagulation, TAVR, TCT 2015
Feature | Antiplatelet and Anticoagulation Therapies | October 20, 2015
October 20, 2015 — Results from the BRAVO 3 trial found that...
Amaranth Fortitute Bioresorbable stent

The Amaranth Fortitute bioresorbable stent was among several fully bioresorbing platforms discussed in sessions, late breaking trial data presentations and on the expo floor at TCT 2015.

Feature | TCT | October 19, 2015 | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT)...
Claret embolic protection, TAVR, cerebral protection

The Claret TAVR embolic protection system as seen in the aortic arch under angiography. The loops contain embolic filters they protect the ostium of vessles leading to the brain.

Feature | Heart Valve Repair | October 16, 2015
October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at...
News | Heart Valve Repair | October 15, 2015
October 15, 2015 — Edwards Lifesciences Corp. announced that details on the 13...
PARTNER II Trial, TCT 2015, Edwards Lifesciences, Sapien 3 valve, one-year results

Image courtesy of Edwards Lifesciences

Feature | Heart Valve Repair | October 15, 2015
October 15, 2015 — One-year patient outcomes from the PARTNER II trial showed the low rate of 30-day complications with...
Sapien XT, VIV, valve in valve
Technology | Heart Valve Repair | October 15, 2015
October 15, 2015 — U.S. Food and Drug Administration (FDA) has cleared Edwards Lifesciences Sapien XT transcatheter...
Boston Scientific, investment, MValve Technologies, first-in-human clinical trial, TMVR, Lotus Valve

Lotus Valve image courtesy of Boston Scientific

News | Heart Valve Repair | October 14, 2015
October 14, 2015 — Boston Scientific Corp. announced it has closed on an additional round of financing with MValve...
Overlay Init